SSA
SLRN

Schonfeld Strategic Advisors’s ACELYRIN SLRN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-202,662
Closed -$2.06M – 2180
2023
Q3 		$2.06M Buy
202,662
+147,454
+267% +$3.13M 0.02% 819
2023
Q2 		$1.15M Buy
+55,208
New +$1.13M 0.01% 925

Other funds holding SLRN

ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schonfeld Strategic Advisors's SLRN Position: Q4 2023 in Review

Schonfeld Strategic Advisors sold out of ACELYRIN (SLRN) in Q4 2023, closing a stake of 202,662 shares — an estimated $2.06M sold.

Schonfeld Strategic Advisors first reported a position in SLRN in Q2 2023 and held it in 2 quarters. The position peaked at $2.06M in Q3 2023. 110 funds tracked by Wall St. Rank hold SLRN as of Q4 2023.

  • Schonfeld Strategic Advisors reported no remaining ACELYRIN position as of Q4 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 202,662 ACELYRIN shares in Q4 2023, an estimated $2.06M.
  • Schonfeld Strategic Advisors first reported a position in ACELYRIN in Q2 2023 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's ACELYRIN position peaked at $2.06M in Q3 2023.
  • 110 funds tracked by Wall St. Rank held ACELYRIN as of Q4 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.